1. Combined treatment synergistically increased sensitivity to TMZ; enhanced apoptosis, increased ROS production, disrupted AKT/mTOR signaling pathways2. Crosses BBB;, decrease activity MMP-9, inhibit glioma angiogenesis; slow tumor growth; increase animal survival. The gene discussed is AKT1; the disease is glioma.